ClinicalTrials.Veeva

Menu

Interaction Between Paracetamol and Lamotrigine: A Clinical Interaction Study

P

Per Damkier

Status and phase

Completed
Phase 4

Conditions

Healthy

Treatments

Drug: Lamotrigine

Study type

Interventional

Funder types

Other

Identifiers

NCT02303106
AKF-386

Details and patient eligibility

About

The investigators will study the effect of paracetamol on the steady state metabolism of lamotrigine in 12 healthy male volunteers.

Subjects will receive lamotrigine, slowly titrated from 25 mg daily to 100 mg daily over 28 days. On day 36, full plasma and urine PK samples will be drawn. On days 37-40 the subject will be co-administered 1 gr paracetamol 4 times daily. On day 40 the sampling will be repeated.

Primary outcome parameter is Lamotrigine AUC before and after coadministration of paracetamol.

Enrollment

12 patients

Sex

Male

Ages

18 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy no medication use
  • Informed consent

Exclusion criteria

  • Allergy to paracetamol or lamotrigine

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

12 participants in 2 patient groups

lamotrigine
Active Comparator group
Description:
lamotrigine alone
Treatment:
Drug: Lamotrigine
Lamotrigine + paracetamol
Experimental group
Description:
Lamotrigine + paracetamol
Treatment:
Drug: Lamotrigine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems